Filing Details

Accession Number:
0001562180-22-007292
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-19 20:59:34
Reporting Period:
2022-10-17
Accepted Time:
2022-10-19 20:59:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404123 1Life Healthcare Inc ONEM Services-Offices & Clinics Of Doctors Of Medicine (8011) 760707204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800511 A Lisa Mango C/O 1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco CA 94111
General Counsel And Secretary No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-17 2,472 $12.16 90,857 No 4 M Direct
Common Stock Disposition 2022-10-17 2,472 $17.06 88,385 No 4 S Direct
Common Stock Acquisiton 2022-10-19 2,500 $11.47 90,885 No 4 M Direct
Common Stock Disposition 2022-10-19 2,500 $17.06 88,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Disposition 2022-10-17 2,472 $0.00 2,472 $12.16
Common Stock Stock Option (Right to Buy) Disposition 2022-10-19 2,500 $0.00 2,500 $11.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
96,420 2032-01-14 No 4 M Direct
57,500 2029-09-18 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
  2. This transaction was executed in multiple trades at prices ranging from $17.045 to $17.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $17.05 to $17.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
  5. On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 98,892 options instead of the reported 91,293. This number has been adjusted for the current filing to reflect the number of options beneficially owned.
  6. The shares subject to the option vest as follows: 20% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vest monthly thereafter over the following four years, subject to reporting person's continuous service as of each such date.
  7. On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 60,000 options instead of the reported 42,564. This number has been adjusted for the current filing to reflect the number of options beneficially owned.